Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EBT (2020 - 2025)

P3 Health Partners (PIII) has disclosed EBT for 6 consecutive years, with -$69.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT rose 34.76% year-over-year to -$69.4 million, compared with a TTM value of -$343.9 million through Sep 2025, down 54.77%, and an annual FY2024 reading of -$306.0 million, down 66.54% over the prior year.
  • EBT was -$69.4 million for Q3 2025 at P3 Health Partners, down from -$41.7 million in the prior quarter.
  • Across five years, EBT topped out at -$24.7 million in Q1 2021 and bottomed at -$903.1 million in Q2 2022.
  • Average EBT over 5 years is -$130.7 million, with a median of -$49.8 million recorded in 2023.
  • The sharpest move saw EBT plummeted 2965.07% in 2022, then surged 96.97% in 2023.
  • Year by year, EBT stood at -$60.2 million in 2021, then plummeted by 780.73% to -$530.5 million in 2022, then soared by 93.05% to -$36.9 million in 2023, then tumbled by 414.14% to -$189.6 million in 2024, then surged by 63.37% to -$69.4 million in 2025.
  • Business Quant data shows EBT for PIII at -$69.4 million in Q3 2025, -$41.7 million in Q2 2025, and -$43.2 million in Q1 2025.